Home / Germany / Nemus Bioscience, Inc.
Nemus Bioscience, Inc.
Short position disclosed on August 25, 2026.
1.09% of the capital sold short
2 disclosing funds
2 disclosures on record
US83086J3095 ISIN code
Evolution of the disclosed total
0%0.5%1%1.5%
Aug 26
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Squarepoint Ops LLC | 0.55% | unchanged | August 25, 2026 | |
| Arrowstreet Capital, Limited Partnership | 0.54% | unchanged | August 25, 2026 |
Get the moves on Nemus Bioscience, Inc. by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| August 25, 2026 | Squarepoint Ops LLC | 0.55% | still open |
| August 25, 2026 | Arrowstreet Capital, Limited Partnership | 0.54% | still open |
Download 2 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Germany
- TUI AG 8.60% of the capital sold short
- HelloFresh SE 7.94% of the capital sold short
- Hugo Boss AG 7.70% of the capital sold short
- AUTO1 Group SE 7.29% of the capital sold short
- Gerresheimer AG 6.47% of the capital sold short
- Aeluma, INC. 6.01% of the capital sold short
- Zalando SE 5.90% of the capital sold short
- Cancom SE 5.55% of the capital sold short
- Scout24 SE 5.29% of the capital sold short
- GameSquare Holdings Inc 5.16% of the capital sold short
- K+S Aktiengesellschaft 5.06% of the capital sold short
- Tamboran Resources Corp. 4.96% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Nemus Bioscience, Inc., source Bundesanzeiger, data as at August 25, 2026, https://www.quivad.com/action/nemus-bioscience-inc